Related references
Note: Only part of the references are listed.HIPEC for colorectal peritoneal metastases
Samuel J. Klempner et al.
LANCET ONCOLOGY (2021)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)
Koen P. Rovers et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Ye Yao et al.
CELL STEM CELL (2020)
Organoid models of gastrointestinal cancers in basic and translational research
Harry Cheuk Hay Lau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Vignesh Narasimhan et al.
CLINICAL CANCER RESEARCH (2020)
Clinical development of therapies targeting TGF beta: current knowledge and future perspectives
D. Ciardiello et al.
ANNALS OF ONCOLOGY (2020)
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Hideaki Ogiwara et al.
CANCER CELL (2019)
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
Koen P. Rovers et al.
BMC CANCER (2019)
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
I. Ubink et al.
BRITISH JOURNAL OF SURGERY (2019)
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Mohammad Alyami et al.
LANCET ONCOLOGY (2019)
Beware mis-representation of PRODIGE 7: danger of throwing out the cytoreductive surgery baby with the hyperthermic intraperitoneal chemotherapy bathwater
Cherry E. Koh et al.
ANZ JOURNAL OF SURGERY (2019)
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh et al.
NATURE MEDICINE (2019)
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Salo N. Ooft et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
Wim Ceelen
EJSO (2019)
Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases
I. Ubink et al.
BRITISH JOURNAL OF SURGERY (2018)
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
Janneke F. Linnekamp et al.
CELL DEATH AND DIFFERENTIATION (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Macrophages induce “budding” in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions
Kari Trumpi et al.
Oncotarget (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
Anne Trinh et al.
CLINICAL CANCER RESEARCH (2017)
A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity
Inge Ubink et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity
Inge Ubink et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Neoadjuvant chemotherapy affects molecular classification of colorectal tumors
K. Trumpi et al.
ONCOGENESIS (2017)
Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling
D. Lynn Kirkpatrick et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang et al.
CELL (2016)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Etienne Becht et al.
CLINICAL CANCER RESEARCH (2016)
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
Jan Franko et al.
LANCET ONCOLOGY (2016)
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes Secondary Analysis of NSABP C-O7/NRG Oncology Randomized Clinical Trial
Nan Song et al.
JAMA ONCOLOGY (2016)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella et al.
NATURE GENETICS (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Human Subperitoneal Fibroblast and Cancer Cell Interaction Creates Microenvironment That Enhances Tumor Progression and Metastasis
Motohiro Kojima et al.
PLOS ONE (2014)
Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
Gordon F. Rushworth et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
Jing Cai et al.
CARCINOGENESIS (2012)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin
E. E. M. Brouwers et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum
Hilary A. Kenny et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Share Paper
